Journal List > J Bacteriol Virol > v.45(1) > 1034175

Lee, Choi, Kim, Song, and Yang: Prevalence and Characterization of Actinobacillus pleuropneumoniae Isolated from Korean Pigs

Abstract

Actinobacillus pleuropneumoniae causes porcine pleuropneumoniae which is one of severe threats to the swine industry. In total, 54 strains of Actinobacillus pleuropneumoniae were isolated from 443 pigs between 2012 and 2013 in Korea. Isolates were classified into serotypes 1, 2, 5, 7, 12, and unclassified by multiplex PCR. Genotypes of isolates were divided into three groups according to the sequence of the omlA gene. The antimicrobial resistance rate of serotype 1 was slightly higher than that of serotype 5. In conclusion, to block and treat porcine pleuropneumonia, it is necessary to conduct ongoing characterization of A. pleuropneumoniae isolated from pigs.

REFERENCES

1). Chatellier S, Harel J, Dugourd D, Chevallier B, Kobisch M, Gottschalk M. Genomic relatedness among Actinobacillus pleuropneumoniae field strains of sterotypes 1 and 5 isolated from healthy and diseased pigs. Can J Vet Res. 1999; 63:170–6.
2). Chiers K, De Waele T, Pasmans F, Ducatelle R, Haesebrouck F. Virulence factors of Actinobacillus pleuropneumoniae involved in colonization, persistence and induction of lesions in its porcine host. Vet Res. 2010; 41:65.
3). Del Pozo Sacristán R, Michiels A, Martens M, Haesebrouck F, Maes D. Efficacy of vaccination against Actinobacillus pleuropneumoniae in two Belgian farrow-to-finish pig herds with a history of chronic pleurish. Vet Rec. 2014; 174:302.
4). Ohba T, Shibahara T, Kobayashi H, Takashima A, Nagoshi M, Araki M, et al. Prevalence of granulomatous pleuropneumonia associated with Actinobacillus pleuropneumoniae serotype 2 in slaughter pigs. J Vet Med Sci. 2009; 71:1089–92.
5). Schuchert JA, Inzana TJ, Angen Ø, Jessing S. Detection and identification of Actinobacillus pleuropneumoniae serotypes 1, 2, and 8 by Multiplex PCR. J Clin Microbiol. 2004; 42:4344–8.
6). Gram T, Ahrens P. Improved diagnostic PCR assay for Actinobacillus pleuropneumoniae based on the nucleotide sequence of an outer membrane lipoprotein. J Clin Microbiol. 1998; 36:443–8.
7). Jung BY, Cho GJ, Kim BH, Cho KH. Biochemical characteristics and serotypes of Actinobacillus pleuropneumoniae isolated from pneumonic lungs of pigs. Korean J Vet Res. 1996; 36:181–6.
8). Schaller A, Kuhn R, Kuhnert P, Nicolet J, Anderson TJ, Maclnnes JI, et al. Characterization of apxIVA, a new RTX determinant of Actinobacillus pleuropneumoniae. Microbiology. 1999; 145:2105–16.
9). Cho WS, Chae C. Genotypic prevalence of apxIV in Actinobacillus pleuropneumoniae field isolates. J Vet Diagn Invest. 2001; 13:175–7.
10). Jessing SG, Angen Ø, Inzana TJ. Evaluation of a multiplex PCR test for simultaneous identification and serotyping of Actinobacillus pleuropneumoniae serotypes 2, 5, and 6. J Clin Microbiol. 2003; 41:4095–100.
11). Lo TM, Ward CK, Inzana TJ. Detection and identification of Actinobacillus pleuropneumoniae serotype 5 by Multiplex PCR. J Clin Microbiol. 1998; 36:1704–10.
12). Shin MK, Cha SB, Lee WJ, Yoo HS. Predicting genetic traits and epitope analysis of apxIVA in Actinobacillus pleuropneumoniae. J Microbiol. 2011; 49:462–8.
13). Rossi CC, de Araújo EF, de Queiroz MV, Bazzolli DM. Characterization of the omlA gene from different serotypes of Actinobacillus pleuropneumoniae: A new insight into an old approach. Genet Mol Biol. 2013; 36:243–51.
14). Dayao DA, Gibson JS, Blackall PJ, Turni C. Antimicrobial resistance in bacteria associated with porcine respiratory disease in Australia. Vet Microbiol. 2014; 171:232–5.
crossref
15). de Jong A, Thomas V, Simjee S, Moyaert H, El Garch F, Maher K, et al. Antimicrobial susceptibility monitoring of respiratory tract pathogens isolated from diseased cattle and pigs across Europe: The VetPath study. Vet Microbiol. 2014; 172:202–15.
crossref
16). Vanni M, Merenda M, Barigazzi G, Garbarino C, Luppi A, Tognetti R, et al. Antimicrobial resistance of Actinobacillus pleuropneumoniae isolated from swine. Vet Microbiol. 2012; 156:172–7.
17). Yoo AN, Cha SB, Shin MK, Won HK, Kim EH, Choi HW, et al. Serotypes and antimicrobial resistance patterns of the recent Korean Actinobacillus pleuropneumoniae isolates. Vet Rec. 2014; 174:223.
18). Kim B, Min K, Choi C, Cho WS, Cheon DS, Kwon D, et al. Antimicrobial susceptibility of Actinobacillus pleuropneumoniae isolated from pigs in Korea using new standardized procedures. J Vet Med Sci. 2001; 63:341–2.
19). Ramjeet M, Deslandes V, Gouré J, Jacques M. Actinobacillus pleuropneumoniae vaccines: from bacterins to new insights into vaccination strategies. Anim Health Res Rev. 2008; 9:25–45.
20). Asawa T, Kobayashi H, Mitani K, Ito N, Morozumi T. Serotypes and antimicrobial susceptibility of Actinobacillus pleuropneumoniae isolated from piglets with pleuropneumonia. J Vet Med Sci. 1995; 57:757–9.

Figure 1.
Alignment among the omlA gene of A. pleuropneumoniae
jbv-45-19f1.tif
Table 1.
PCR condition for serotyping of A. pleuropneumoniae
Name Responsible Primer sequence Size (bp) Ref.
AP1F Forward primer for cps region of serotype 1 5′-AGTGGCTGGATGAGACGAGAC-3′ 1,600 (5)
AP1R Reverse primer for cps region of serotype 1 5′-TAGTTTGTTATGGTATTTCTGTA-3′
AP2F Forward primer for cps region of serotype 2 5′-ACTATGGCAATCAGTCGATTCAT-3′ 500 (10)
AP2R Reverse primer for cps region of serotype 2 5′-CCTAATCGGAAACGCCATTCTG-3′
AP3F Forward primer for cps region of serotype 3 5′-TTTGCGCTGTAGTGCTCCAAT-3′ 900 This study
AP3R Reverse primer for cps region of serotype 3 5′-AACAAATAAAGTTGCTCGAAAGTA-3′
AP5F Forward primer for cps region of serotype 5 5′-TTTATCACTATCACCGTCCACACCT-3′ 1,100 (10)
AP5R Reverse primer for cps region of serotype 5 5′-CATTCGGGTCTTGTGGCTACTAA-3′
AP6F Forward primer for cps region of serotype 6 5′-AACCACTCACTTTCCACATTAG-3′ 720 (10)
AP6R Reverse primer for cps region of serotype 6 5′-AATCGGAAGGTTTTGGTCTCGTG-3′
AP7F Forward primer for cps region of serotype 7 5′-GGTGACTGGCGTACGCCAAA-3′ 400 This study
AP7R Reverse primer for cps region of serotype 7 5′-GGGCTGCAGACTGACGTAA-3′
AP8F Forward primer for cps region of serotype 8 5′-AACGGCTTTTGAACAACTTTATTTATTT-3′ 1,000 (5)
AP8R Reverse primer for cps region of serotype 8 5′-TTCATTCCTAAACTCCGTATTGTCA-3′
AP12F Forward primer for cps region of serotype 12 5′-GGTTCTCCAGATGACTCTGAAA-3′ 600 This study
AP12R Reverse primer for cps region of serotype 12 5′-GCTATTGGATGAAGATGACTCAT-3′
Table 2.
Classification of A. pleuroneumoniae based on omlA gene sequence
Serotype Strain KVCC No. Date Province Genotype (omlA gene)
A. pleuroneumoniae KVCC-BA1400162 2012.07.06. Jeonbuk I
A. pleuroneumoniae KVCC-BA1400164 2012.07.10. Chungbuk I
A. pleuroneumoniae KVCC-BA1400165 2012.07.17. Gyeonggi I
A. pleuroneumoniae KVCC-BA1400171 2012.11.20. Gyeonggi I
A. pleuroneumoniae KVCC-BA1400174 2012.11.27. Chungnam I
A. pleuroneumoniae KVCC-BA1400176 2013.02.15. Chungnam I
A. pleuroneumoniae KVCC-BA1400182 2013.03.15. Chungnam I
1 (n=15) A. pleuroneumoniae KVCC-BA1400193 2013.12.18. Chungnam I
A. pleuroneumoniae KVCC-BA1400196 2012.01.02. Chungnam I
A. pleuroneumoniae KVCC-BA1400213 2012.01.06. Chungbuk I
A. pleuroneumoniae KVCC-BA1400214 2012.01.06. Gyeongnam I
A. pleuroneumoniae KVCC-BA1400221 2012.04.20. Jeonbuk I
A. pleuroneumoniae KVCC-BA1400222 2012.05.02. Chungnam I
A. pleuroneumoniae KVCC-BA1400223 2012.05.02. Chungnam I
A. pleuroneumoniae KVCC-BA1400170 2012.11.20. Chungnam I
A. pleuroneumoniae KVCC-BA1400167 2012.09.03. Gyeongbuk II
A. pleuroneumoniae KVCC-BA1400173 2012.11.21. Chungnam II
2 (n=4) A. pleuroneumoniae KVCC-BA1400181 2013.03.08. Gyeongnam II
A. pleuroneumoniae KVCC-BA1400188 2013.08.28 Chungnam II
A. pleuroneumoniae KVCC-BA1400163 2012.07.10. Gyeongnam III
A. pleuroneumoniae KVCC-BA1400169 2012.09.19. Gyeongbuk III
A. pleuroneumoniae KVCC-BA1400172 2012.11.21. Gyeonggi III
A. pleuroneumoniae KVCC-BA1400175 2012.12.21. Gyeongbuk III
A. pleuroneumoniae KVCC-BA1400178 2013.02.28. Gyeongnam III
A. pleuroneumoniae KVCC-BA1400184 2013.04.08. Chungnam III
A. pleuroneumoniae KVCC-BA1400185 2013.04.24. Chungnam III
A. pleuroneumoniae KVCC-BA1400186 2013.04.24. Chungnam III
A. pleuroneumoniae KVCC-BA1400187 2013.06.07. Gyeongbuk III
A. pleuroneumoniae KVCC-BA1400189 2013.11.06. Chungnam III
5 (n=20) A. pleuroneumoniae KVCC-BA1400190 2013.11.11. Chungbuk III
A. pleuroneumoniae KVCC-BA1400191 2013.11.13. Chungnam III
A. pleuroneumoniae KVCC-BA1400192 2013.11.18. Gyeonggi III
A. pleuroneumoniae KVCC-BA1400194 2013.12.27. Chungbuk III
A. pleuroneumoniae KVCC-BA1400195 2012.01.02. Chungbuk III
A. pleuroneumoniae KVCC-BA1400216 2012.03.07. Gyeongbuk III
A. pleuroneumoniae KVCC-BA1400217 2012.03.08. Chungnam III
A. pleuroneumoniae KVCC-BA1400219 2012.04.06. Chungnam III
A. pleuroneumoniae KVCC-BA1400220 2013.04.20. Gyeongbuk III
A. pleuroneumoniae KVCC-BA1400226 2013.05.25. Gyeongnam III
7 (n=1) A. pleuroneumoniae KVCC-BA1400212 2012.01.06. Gyeongnam *
12 (n=1) A. pleuroneumoniae KVCC-BA1400179 2013.02.28. Chungnam
A. pleuroneumoniae KVCC-BA1400197 2012.01.02. Chungnam I
A. pleuroneumoniae KVCC-BA1400211 2012.01.02. Chungnam I
A. pleuroneumoniae KVCC-BA1400215 2012.03.02. I
A. pleuroneumoniae KVCC-BA1400218 2012.04.04. Gyeongbuk I
A. pleuroneumoniae KVCC-BA1400224 2012.05.04. Gyeonggi I
A. pleuroneumoniae KVCC-BA1400225 2012.05.24. Gyeongbuk I
Unclassified (n=13) A. pleuroneumoniae KVCC-BA1400227 2012.05.25. Chungnam I
A. pleuroneumoniae KVCC-BA1400228 2012.06.11. Chungbuk
A. pleuroneumoniae KVCC-BA1400166 2012.08.24. Chungnam I
A. pleuroneumoniae KVCC-BA1400168 2012.09.17. Gyeongbuk
A. pleuroneumoniae KVCC-BA1400177 2013.02.15. Gyeongbuk
A. pleuroneumoniae KVCC-BA1400180 2013.03.08. Gyeongnam III
A. pleuroneumoniae KVCC-BA1400183 2013.03.18. Gyeonggi I

* − No detection.

Table 3.
Numbers of A. pleuropneumoniae isolates from pigs between 2012 to 2013
Isolation yr
Total
2012 2013
No. of pig 177 266 443
No. of A. pleuropneumoniae 35 19 54
 Serotype 1 12 3 15
 Serotype 2 2 2 4
 Serotype 3 0 0 0
 Serotype 5 10 10 20
 Serotype 6 0 0 0
 Serotype 7 1 0 1
 Serotype 8 0 0 0
 Serotype 12 0 1 1
 Unclassified 10 3 13
Table 4.
MIC90 and antimicrobial resistance rates of A. pleuroneumoniae (Serotype 1 and 5)
Antimicrobial agents Breakpoint Serotype 1 (n=15)
Serotype 5 (n=20)
MIC90 Resistance (%) MIC90 Resistance (%)
Ampicillin * ≥16 ≤0.25
Penicillin * ≥8 0.25
Ceftiofur ≥8 ≤0.25 0.00% ≤0.25 0.00%
Danofloxacin ≥0.25 1 80.00% 1 50.00%
Enrofloxacin ≥2 0.5 0.00% 0.5 0.00%
Spectinomycin * 64 64
Gentamicin ≥16 16 60.00% ≥16 20.00%
Neomycin * ≥32 ≥32
Tilmicosin ≥32 8 0.00% 8 0.00%
Tulathromycin ≥64 32 6.70% 16 0.00%
Florfenicol ≥8 ≥8 67.0% 8 10.0%
Tiamulin ≥32 16 13.3% 16 0.00%
Chlortetracycline ≥16 4 0.00% 4 0.00%

* There is no antimicrobial breakpoint in the Clinical Laboratory Standard Institute (CLSI) guideline.

TOOLS
Similar articles